Overview

Set to take place on 13th and 14th April, SMI’s sell-out Asthma & COPD conference returns to London next spring for its 11th annual show. With the global market for asthma and COPD drugs set to reach $41.23bn in 2017, Asthma & COPD 2015 comes at the perfect time to explore the future of therapeutics, diagnosis and care.

We have worked closely with a leading panel of experts such as Genentech, GSK, MedImmune, Amgen and Imperial College of London, to create an agenda that will provide unique insights into topics such as lab to clinic pathways, personalised care, viruses in asthma and COPD, future advancements, PLUS MUCH MORE

Join us we ask questions such as: How is severe asthma in children pathophysiologically different to the adult disease? Is airway remodelling dependent on inflammation? What value can patient charities bring to multi-partner collaborations? What are the drug development challenges associated with inhaled and intranasal antivirals? What are the key areas of unmet clinical needs for COPD clinical care?

REASONS TO ATTEND
• Explore the future of asthma and COPD treatment from a range of key perspectives
• Discover advances in inhaled therapies
• Discuss personalised therapy approaches, asthma patient stratification and unmet needs
• Share in the latest thinking from the clinic to improve the lives of patients
• Explore the latest thinking on biomarkers and clinical trial endpoints
• Update on mechanisms and treatment for viral induced COPD and asthma exacerbations

KEY SPEAKERS INCLUDE:
• Sebastian Johnston, Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College London – Conference Chair
• Robert Niven, Senior Lecturer in Respiratory Medicine, Manchester University – Conference Chair
• Neil C Thomson, Professor of Respiratory Medicine, University of Glasgow
• Joseph Arron, Associate Director, Biomarker Discovery, Genentech, Inc.
• Dirk Smith, Scientific Director, Amgen
• U Roland Kolbeck, Senior Director, Respiratory, Inflammation & Autoimmunity, MedImmune
• Hector Ortega, Medical Director, Respiratory R&D, GSK
• Maria Buxton, Consultant Respiratory Physiotherapist, London North West Healthcare NHS Trust

SMi Group has been at the forefront of respiratory conferences for over a decade. Comments from previous instalments in the established series include: “Excellent, both days” – Prosonix, “Good Networking opportunities” – Novartis and “Good level of speaker expertise, worthwhile to attend” Biomedical systems

For further information and to secure your place, visit: www.asthma-copd.co.uk
Alternatively contact the team on +44 (0)20 7827 6000 or email events@smi-online.co.uk



Venue: Holiday Inn Regents Park Hotel
Location: Carburton Street, London
Country: United Kingdom

Organiser Contact Details:
Teri Arri
T: +44 (0)20 7827 6000
tarri@smi-online.co.uk